Digital Health Global
OCTOBER 11, 2023
The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges.
Health Populi
MAY 20, 2021
to approve Medicare’s negotiation of drug prices with pharmaceutical companies]. The one segment which has stayed relatively even from 2018 has been biotech, 55% that year and 55% again in 2021. health citizens’ memories will last into 2022 with respect to cross-party desire for the U.S. On these factors, the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
MARCH 1, 2023
With over 20 years of experience in pharmaceutical, medtech, digital health, biotech and diagnosis, Julie’s leadership approach focuses on inspiring teams to deliver sustainable growth in challenging markets and healthcare environments. Mundipharma is a global pharmaceutical leader. Tanda, Aptar President and CEO.
Digital Health Global
AUGUST 2, 2023
Colin’s track record with global biopharma and biotech partners is extensive and admirable,” added Chris Garabedian, a VivoSense Board Member. “He Colin has demonstrated strong leadership to his teams and customers alike.” For more information, visit www.vivosense.com. We are on Twitter. Follow us @vivosense.
Health Populi
MARCH 11, 2021
Speaking of design, this Summit was indeed well-designed by spotlighting pragmatic representatives from these various stakeholder groups.
Digital Health Global
MARCH 16, 2023
Both Wellington and Forbion are visionaries and highly experienced biotech investors, and we look forward to working closely with them in our efforts to transform the gene editing landscape.” “Our Forbion invests in life sciences companies that are active in the (bio) pharmaceutical space. Forbion manages well over EUR 2.3
Healthcare IT Today
APRIL 4, 2023
Dell Technologies has developed a suite of digital twin solutions that are specifically designed to accelerate the biotech development process at every stage with patient digital twins. We’ll be able to create complex protocols for studying every aspect of chronic conditions and maybe someday resolving it.
Expert insights. Personalized for you.
167 
Let's personalize your content